Impact of Anemia on Exercise and Pharmacologic Stress Echocardiography.

Anemia Coronary artery disease Dobutamine stress echocardiography Echocardiography Exercise stress echocardiography Stress testing

Journal

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography
ISSN: 1097-6795
Titre abrégé: J Am Soc Echocardiogr
Pays: United States
ID NLM: 8801388

Informations de publication

Date de publication:
09 2020
Historique:
received: 02 12 2019
revised: 01 04 2020
accepted: 01 04 2020
pubmed: 28 7 2020
medline: 25 9 2021
entrez: 26 7 2020
Statut: ppublish

Résumé

The safety and diagnostic accuracy of stress testing in anemic patients have not been well studied. Despite a lack of data, significant anemia may be considered a relative contraindication to stress testing because of safety concerns related to insufficient myocardial oxygen supply. The authors reviewed 28,829 consecutive patients with blood hemoglobin drawn within 48 hours of stress echocardiography (15,624 exercise and 13,205 dobutamine). The associations of blood hemoglobin concentration with arrhythmia and other stress echocardiographic findings were examined. Additionally, the effect of anemia on the positive predictive value of stress echocardiography for the detection of significant coronary artery stenosis (≥50%) was assessed in patients who subsequently underwent coronary angiography. Anemia was present in 6,401 patients (22.2%) and was severe (hemoglobin < 8.0 g/dL) in 52. Stress testing with either exercise or dobutamine was safe, with no significant increase in serious arrhythmia events or need for hospitalization. In the exercise cohort, worsening anemia was associated with reduced treadmill exercise time, lower peak heart rate, peak rate-pressure product, and achieved workload. In the dobutamine stress cohort, worsening anemia was associated with higher resting heart rate, more use of atropine, and fewer patients attaining target heart rate. The positive predictive value of stress echocardiography was higher in patients with moderate anemia compared with those without anemia (71.8% vs 60.2%, P = .01). This study demonstrates that stress testing is safe in patients with mild and moderately anemia, albeit with a small increase in mild supraventricular arrhythmias with exercise. However, worsening anemia was associated with a significant reduction in exercise capacity. Additionally, worsening anemia was associated with an improvement in the positive predictive value of stress echocardiography. Extrapolation of these data to patients with severe anemia should be performed with caution given the limited number of patients with severe anemia in this study.

Sections du résumé

BACKGROUND
The safety and diagnostic accuracy of stress testing in anemic patients have not been well studied. Despite a lack of data, significant anemia may be considered a relative contraindication to stress testing because of safety concerns related to insufficient myocardial oxygen supply.
METHODS
The authors reviewed 28,829 consecutive patients with blood hemoglobin drawn within 48 hours of stress echocardiography (15,624 exercise and 13,205 dobutamine). The associations of blood hemoglobin concentration with arrhythmia and other stress echocardiographic findings were examined. Additionally, the effect of anemia on the positive predictive value of stress echocardiography for the detection of significant coronary artery stenosis (≥50%) was assessed in patients who subsequently underwent coronary angiography.
RESULTS
Anemia was present in 6,401 patients (22.2%) and was severe (hemoglobin < 8.0 g/dL) in 52. Stress testing with either exercise or dobutamine was safe, with no significant increase in serious arrhythmia events or need for hospitalization. In the exercise cohort, worsening anemia was associated with reduced treadmill exercise time, lower peak heart rate, peak rate-pressure product, and achieved workload. In the dobutamine stress cohort, worsening anemia was associated with higher resting heart rate, more use of atropine, and fewer patients attaining target heart rate. The positive predictive value of stress echocardiography was higher in patients with moderate anemia compared with those without anemia (71.8% vs 60.2%, P = .01).
CONCLUSIONS
This study demonstrates that stress testing is safe in patients with mild and moderately anemia, albeit with a small increase in mild supraventricular arrhythmias with exercise. However, worsening anemia was associated with a significant reduction in exercise capacity. Additionally, worsening anemia was associated with an improvement in the positive predictive value of stress echocardiography. Extrapolation of these data to patients with severe anemia should be performed with caution given the limited number of patients with severe anemia in this study.

Identifiants

pubmed: 32709477
pii: S0894-7317(20)30212-1
doi: 10.1016/j.echo.2020.04.003
pii:
doi:

Substances chimiques

Dobutamine 3S12J47372

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1067-1076

Informations de copyright

Copyright © 2020 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Auteurs

Jared G Bird (JG)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.

Kareem Morant (K)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.

Deema Al-Souri (D)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.

Christopher G Scott (CG)

Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.

Ratnasari Padang (R)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.

Robert B McCully (RB)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.

Garvan C Kane (GC)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.

Patricia A Pellikka (PA)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.

Sushil Allen Luis (SA)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: luis.s@mayo.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH